netFormulary
 Report : A-Z HCD items in Formulary 27/10/2020 18:25:35
[Back]
 
Section Status HCD Name
03.04.02 Formulary Cancer Drugs Fund Omalizumab Xolair®
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia®
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios®
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone acetate Zytiga®
01.05.03 Formulary Cancer Drugs Fund Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
10.01.03 Formulary Cancer Drugs Fund Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
11.04.01 Formulary Cancer Drugs Fund Adalimumab  Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
13.05.03 Formulary Cancer Drugs Fund Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
13.06 Formulary Cancer Drugs Fund Adalimumab Hyrimoz®, Amgevita®, Imraldi®, Hulio®, Humira®
05.03.03.01 Formulary Cancer Drugs Fund Adefovir Dipivoxil Hepsera®
08.01.05 Formulary Cancer Drugs Fund Afatinib dimaleate Giotrif®
11.08.02 Formulary Cancer Drugs Fund Aflibercept Eylea®
08.01.05 Formulary Cancer Drugs Fund Alectinib hydrochloride Alecensa®
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada®
02.12 Formulary Cancer Drugs Fund Alirocumab Praluent®
13.05.01 Formulary Cancer Drugs Fund Alitretinoin Toctino®
02.05.01 Formulary Cancer Drugs Fund Ambrisentan Volibris®
10.02.01 Formulary Cancer Drugs Fund Amifampridine Firdapse®
10.01.03 Formulary Cancer Drugs Fund Anakinra Kineret®
10.01.03 Formulary Cancer Drugs Fund Apremilast Otezla®
13.05.03 Formulary Cancer Drugs Fund Apremilast Otezla®
08.01.05 Formulary Cancer Drugs Fund Arsenic trioxide Trisenox®
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
09.01.04 Formulary Cancer Drugs Fund Avatrombopag Doptelet®
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio®
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleucel Yescarta®
08.01.05 Formulary Cancer Drugs Fund Axitinib Inlyta®
08.01.03 Formulary Cancer Drugs Fund Azacitidine Vidaza®
05.01.02.03 Formulary Cancer Drugs Fund Aztreonam lysine powder nebuliser solution Cayston®
10.01.03 Formulary Cancer Drugs Fund Baricitinib Olumiant®
08.02.02 Formulary Cancer Drugs Fund Basiliximab Simulect®
10.01.03 Formulary Cancer Drugs Fund Belimumab Benlysta®
08.01.01 Formulary Cancer Drugs Fund Bendamustine hydrochloride 
03.04.02 Formulary Cancer Drugs Fund Benralizumab Fasenra®
03.05.02 Formulary Cancer Drugs Fund Beractant Survanta®
08.02.03 Formulary Cancer Drugs Fund Blinatumomab Blincyto®
05.03.03.02 Formulary Cancer Drugs Fund Boceprevir Victrelis®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A Botox®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Brigatinib Alunbrig®
13.05.03 Formulary Cancer Drugs Fund Brodalumab Kyntheum®
03.04.03 Formulary Cancer Drugs Fund C1 esterase inhibitor 
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cabometyx®
04.08.01 Formulary Cancer Drugs Fund Cannabidiol Epidyolex®
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis®
08.01.01 Formulary Cancer Drugs Fund Carmustine Gliadel®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia®
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.03 Formulary Cancer Drugs Fund Cladribine Mavenclad ®
05.01.07 Formulary Cancer Drugs Fund Colistimethate Promixin®
05.01.07 Formulary Cancer Drugs Fund Colistimethate Inhaler Colobreathe®
10.03.01 Formulary Cancer Drugs Fund Collagenase Xiapex®
03.04.03 Formulary Cancer Drugs Fund Conestat Alfa Ruconest®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.03 Formulary Cancer Drugs Fund Cytarabine–daunorubicin liposomal  Vyxeos®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib mesilate Tafinlar®
05.03.03.02 Formulary Cancer Drugs Fund Daclatasvir  Daklinza®
08.02.04 Restricted Use Cancer Drugs Fund Daclizumab Zinbryta®
08.01.05 Formulary Cancer Drugs Fund Dacomitinib Vizimpro®
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex®
09.01.03 Formulary Cancer Drugs Fund Darbepoetin Alfa Aranesp®
05.03.03.02 Formulary Cancer Drugs Fund Dasabuvir Sodium Monohydrate Exviera®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
20 Non Formulary Cancer Drugs Fund DAUNORUBICIN saline pre-filled syringe 
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Capsules 400 mg 
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Injection 200 mg 
06.06.02 Formulary Cancer Drugs Fund Denosumab 
11.04.01 Formulary Cancer Drugs Fund Dexamethasone  Ozurdex®
08.03.01 Formulary Cancer Drugs Fund Diethylstilbestrol 
02.01.01 Formulary Cancer Drugs Fund Digifab® 
18 Non Formulary Cancer Drugs Fund Digoxin specific antibody fragments Digifab®
08.02.04 Formulary Cancer Drugs Fund Dimethyl fumarate Tecfidera®
13.05.03 Formulary Cancer Drugs Fund Dimethyl Fumarate  Skilarence®
08.01.05 Formulary Cancer Drugs Fund Dinutuximab beta Qarziba®
08.01.05 Formulary Cancer Drugs Fund Docetaxel 
03.07 Formulary Cancer Drugs Fund Dornase Alfa Pulmozyme®
08.01.05 Formulary Cancer Drugs Fund Doxorubicin hydrochloride Caelyx®
13.05.03 Formulary Cancer Drugs Fund Dupilumab Dupixent®
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
09.01.03 Formulary Cancer Drugs Fund Eculizumab Soliris®
05.03.03.02 Formulary Cancer Drugs Fund Elbasvir & Grazoprevir Zepatier®
09.08.01 Formulary Cancer Drugs Fund Elosulfase alfa Vimizim®
09.01.04 Formulary Cancer Drugs Fund Eltrombopag  Revolade®
08.01.05 Formulary Cancer Drugs Fund Encorafenib  Braftovi®
05.03.03.01 Formulary Cancer Drugs Fund Entecavir Monohydrate Baraclude®
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi®
09.01.03 Formulary Cancer Drugs Fund Epoetin Alfa  Eprex®
09.01.03 Formulary Cancer Drugs Fund Epoetin Beta NeoRecormon®
09.01.03 Formulary Cancer Drugs Fund Epoetin Zeta Retacrit®
02.08.01 Formulary Cancer Drugs Fund Epoprostenol Flolan®
20 Non Formulary Cancer Drugs Fund Eptotermin Alfa  Osigraft®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Erlotinib hydrochloride Tarceva®
10.01.03 Formulary Cancer Drugs Fund Etanercept Enbrel®, Benepali®, Erelzi®
13.05.03 Formulary Cancer Drugs Fund Etanercept Enbrel®, Benepali®, Erelzi®
08.01.05 Formulary Cancer Drugs Fund Everolimus 
02.12 Formulary Cancer Drugs Fund Evolocumab Repatha®
10.02.01 Formulary Cancer Drugs Fund Fampridine Fampyra®
08.02.04 Formulary Cancer Drugs Fund Fingolimod Gilenya®
08.01.03 Formulary Cancer Drugs Fund Fludarabine phosphate 
11.04.01 Formulary Cancer Drugs Fund Fluocinolone acetonide Iluvien®
18 Non Formulary Cancer Drugs Fund Fomepizole 
03.01.01.01 Formulary Cancer Drugs Fund Formoterol Fumarate 
04.07.04.02 Formulary Cancer Drugs Fund Fremanezumab 
08.01.05 Formulary Cancer Drugs Fund Gefitinib Iressa®
08.01.03 Formulary Cancer Drugs Fund Gemcitabine 
08.01.05 Formulary Cancer Drugs Fund Gemtuzumab ozogamicin Mylotarg®
08.02.04 Formulary Cancer Drugs Fund Glatiramer acetate Copaxone®
05.03.03.02 Formulary Cancer Drugs Fund Glecaprevir & Pibrentasvir Maviret®
18 Non Formulary Cancer Drugs Fund Glucarpidase Carboxypeptidase
01.05.03 Formulary Cancer Drugs Fund Golimumab Simponi®
10.01.03 Formulary Cancer Drugs Fund Golimumab Simponi®
13.05.03 Formulary Cancer Drugs Fund Guselkumab Tremfya®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
03.04.03 Formulary Cancer Drugs Fund Icatibant Firazyr®
08.01.05 Formulary Cancer Drugs Fund Idelalisib Zydelig®
08.01.05 Formulary Cancer Drugs Fund Imatinib mesilate 
01.05.03 Formulary Cancer Drugs Fund Infliximab Flixabi®, Inflectra®, Remicade®, Remsima®
10.01.03 Formulary Cancer Drugs Fund Infliximab Flixabi®, Inflectra®, Remicade®, Remsima®
13.05.03 Formulary Cancer Drugs Fund Infliximab Flixabi®, Inflectra®, Remicade®, Remsima®
08.01.05 Formulary Cancer Drugs Fund Inotuzumab ozogamicin Besponsa®
08.02.04 Formulary Cancer Drugs Fund Interferon Beta 
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
03.07 Formulary Cancer Drugs Fund Ivacaftor Kalydeco®
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro®
10.01.03 Formulary Cancer Drugs Fund Ixekizumab Taltz®
13.05.03 Formulary Cancer Drugs Fund Ixekizumab Taltz®
03.04.03 Formulary Cancer Drugs Fund Lanadelumab Takhzyro®
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide acetate 
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide acetate 
09.05.02.02 Formulary Cancer Drugs Fund Lanthanum carbonate Fosrenol®
08.01.05 Formulary Cancer Drugs Fund Larotrectinib 
05.03.03.02 Formulary Cancer Drugs Fund Ledipasvir & Sofosbuvir Harvoni®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid®
09.01.06 Formulary Cancer Drugs Fund Lenograstim Granocyte®
08.01.05 Formulary Cancer Drugs Fund Lenvatinib 
05.03.02.02 Formulary Cancer Drugs Fund Letermovir Prevymis®
05.01.12 Formulary Cancer Drugs Fund Levofloxacin nebuliser solution Quinsair®
08.01.05 Formulary Cancer Drugs Fund Lorlatinib 
09.01.04 Formulary Cancer Drugs Fund Lusutrombopag Mulpleo®
08.03.04.03 Formulary Cancer Drugs Fund Lutetium (177Lu) oxodotreotide 
03.07 Formulary Cancer Drugs Fund Mannitol inhalation Bronchitol ®
06.07.04 Formulary Cancer Drugs Fund Mecasermin Increlex®
03.04.02 Restricted Use Cancer Drugs Fund Mepolizumab Nucala®
08.01.05 Formulary Cancer Drugs Fund Midostaurin Rydapt ®
08.02.04 Formulary Cancer Drugs Fund Mifamurtide Mepact®
08.02.04 Formulary Cancer Drugs Fund Natalizumab Tysabri®
08.03.04.01 Formulary Cancer Drugs Fund Neratinib Nerlynx®
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna®
08.01.05 Formulary Cancer Drugs Fund Nintedanib esilate 
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula®
20 Non Formulary Cancer Drugs Fund Nitazoxanide 
08.01.05 Formulary Cancer Drugs Fund Nivolumab Opdivo®
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Intramuscular use 
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Intravenous use 
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Subcutaneous use 
10.02 Formulary Cancer Drugs Fund Nusinersen Spinraza ®
01.09.01 Restricted Use Cancer Drugs Fund Obeticholic acid 
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro®
08.02.03 Formulary Cancer Drugs Fund Ocrelizumab Ocrevus®
11.08.02 Formulary Cancer Drugs Fund Ocriplasmin Jetrea®
08.03.04.03 Formulary Cancer Drugs Fund Octreotide acetate 
08.03.04.03 Formulary Cancer Drugs Fund Octreotide acetate 
08.02.03 Formulary Cancer Drugs Fund Ofatumumab Arzerra®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo®
05.03.03.02 Formulary Cancer Drugs Fund Ombitasvir, paritaprevir & ritonavir Viekirax®
08.01.05 Formulary Cancer Drugs Fund Osimertinib Tagrisso®
08.01.05 Formulary Cancer Drugs Fund Oxaliplatin 
08.01.05 Formulary Cancer Drugs Fund Paclitaxel 
08.01.05 Formulary Cancer Drugs Fund Palbociclib Ibrance®
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Formulary Cancer Drugs Fund Pazopanib Votrient®
08.01.05 Formulary Cancer Drugs Fund Pegaspargase Oncaspar®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta-1a Plegridy®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed disodium Alimta®
07.04.03 Formulary Cancer Drugs Fund Pentosan polysulfate sodium Elmiron®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
03.11 Formulary Cancer Drugs Fund Pirfenidone Esbriet®
08.01.02 Formulary Cancer Drugs Fund Pixantrone dimaleate Pixuvri®
09.01.07 Formulary Cancer Drugs Fund Plerixafor Mozobil®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
03.05.02 Formulary Cancer Drugs Fund Poractant Alfa Curosurf®
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis®
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
03.04.02 Formulary Cancer Drugs Fund Reslizumab Cinquil®
05.03.03.02 Formulary Cancer Drugs Fund Ribavirin 
08.01.05 Formulary Cancer Drugs Fund Ribociclib succinate Kisqali®
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek®
13.05.03 Formulary Cancer Drugs Fund Risankizumab Skyrizi®
08.02.03 Formulary Cancer Drugs Fund Rituximab MabThera®, Rixathon®, Truxima®
10.01.03 Formulary Cancer Drugs Fund Rituximab MabThera®, Rixathon®, Truxima®
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate®
08.02.04 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib phosphate Jakavi®
10.01.03 Formulary Cancer Drugs Fund Sarilumab Kevzara®
10.01.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx®
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx®
05.03.03.02 Formulary Cancer Drugs Fund Simeprevir Olysio®
20 Non Formulary Cancer Drugs Fund Sipuleucel- T 
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir & Velpatasvir Epclusa®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir, velpatasvir & voxilaprevir Vosevi®
06.05.01 Formulary Cancer Drugs Fund Somatropin 
08.01.05 Formulary Cancer Drugs Fund Sorafenib tosylate Nexavar®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.01.05 Formulary Cancer Drugs Fund Talimogene laherparepvac Imlygic®
20 Non Formulary Cancer Drugs Fund Taribavirin 
05.03.03.02 Formulary Cancer Drugs Fund Telaprevir Incivo®
08.01.05 Formulary Cancer Drugs Fund Temozolomide 
05.03.03.01 Formulary Cancer Drugs Fund Tenofovir Disproxil Viread®
05.03.01 Formulary Cancer Drugs Fund Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®
08.02.04 Formulary Cancer Drugs Fund Teriflunomide Aubagio®
06.06.01 Formulary Cancer Drugs Fund Teriparatide Forsteo®
20 Non Formulary Cancer Drugs Fund TETRAHYDROBIOPTERIN Tablets 10 mg 
08.02.04 Formulary Cancer Drugs Fund Thalidomide Celgene®
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Ilumetri®
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah®
08.01.05 Formulary Cancer Drugs Fund Tivozanib Fotivda®
05.01.04 Formulary Cancer Drugs Fund Tobramycin dry powder for inhalation Tobi® Podhaler
10.01.03 Formulary Cancer Drugs Fund Tocilizumab RoActemra®
01.05.03 Formulary Cancer Drugs Fund Tofacitinib Xeljanz®
10.01.03 Formulary Cancer Drugs Fund Tofacitinib  Xeljanz®
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Jinarc®
08.01.05 Formulary Cancer Drugs Fund Topotecan Hycamtin®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab 
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine 
20 Non Formulary Cancer Drugs Fund Treprostinil  
08.01.05 Formulary Cancer Drugs Fund Trifluridine-tipiracil Lonsurf®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
13.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
01.05.03 Formulary Cancer Drugs Fund Vedolizumab Entyvio®
08.01.05 Formulary Cancer Drugs Fund Vemurafenib Zelboraf®
11.08.02 Formulary Cancer Drugs Fund Verteporfin Visudyne®
North Staffordshire Joint Formulary